
Old Browser
Looks like you're visiting us from United States.
Would you like to stay on the current country site or be switched to your country?
BD Pharmingen™ Purified NA/LE Rat Anti-Mouse CD366 (TIM-3)
Clone RMT3-23 (RUO)

Flow cytometric analysis of Recombinant Mouse TIM-3 protein binding blockade to phosphatidylserine expressed on apoptotic Mouse thymocytes by Purified NA/LE Rat Anti-Mouse CD366 (TIM-3) antibody. BALB/c Mouse thymocytes were cultured in the presence of 1 µM of Dexamethasone for 5 h (37°C) to induce apoptosis. Apoptotic thymocytes (1 x 10^6 cells/0.1 ml final volume) were mixed with Recombinant Mouse TIM-3 Fc Chimera Protein (5 µg test dose; R&D Systems, Cat. No. 1529-TM-050) preincubated (30 min 4°C) with either Purified NA/LE Rat Anti-Mouse CD366 (TIM-3) antibody (Cat. No. 569318; Solid Line) or Purified NA/LE Rat IgG2a Isotype Control (Cat. No. 554687; Dotted Line) at the indicated test doses. The cells were washed and secondarily stained with Biotin Goat Anti-Human IgG, Fc fragment specific (Biotin Anti-Human IgG Fc; Jackson ImmunoResearch, Cat. No. 109-065-190) followed by PE Streptavidin (Cat. No. 554061). The graphs showing the percentage of cells bound with Recombinant TIM-3+ (% Recombinant TIM-3+ Cells) after preincubation with TIM-3-specific Blocking Antibody (or Ig Isotype Control) were derived from gated events with the forward and side light-scatter characteristics of apoptotic thymocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa™ X-20 and FlowJo™ software. Data shown on this Technical Data Sheet are not lot specific.


Flow cytometric analysis of Recombinant Mouse TIM-3 protein binding blockade to phosphatidylserine expressed on apoptotic Mouse thymocytes by Purified NA/LE Rat Anti-Mouse CD366 (TIM-3) antibody. BALB/c Mouse thymocytes were cultured in the presence of 1 µM of Dexamethasone for 5 h (37°C) to induce apoptosis. Apoptotic thymocytes (1 x 10^6 cells/0.1 ml final volume) were mixed with Recombinant Mouse TIM-3 Fc Chimera Protein (5 µg test dose; R&D Systems, Cat. No. 1529-TM-050) preincubated (30 min 4°C) with either Purified NA/LE Rat Anti-Mouse CD366 (TIM-3) antibody (Cat. No. 569318; Solid Line) or Purified NA/LE Rat IgG2a Isotype Control (Cat. No. 554687; Dotted Line) at the indicated test doses. The cells were washed and secondarily stained with Biotin Goat Anti-Human IgG, Fc fragment specific (Biotin Anti-Human IgG Fc; Jackson ImmunoResearch, Cat. No. 109-065-190) followed by PE Streptavidin (Cat. No. 554061). The graphs showing the percentage of cells bound with Recombinant TIM-3+ (% Recombinant TIM-3+ Cells) after preincubation with TIM-3-specific Blocking Antibody (or Ig Isotype Control) were derived from gated events with the forward and side light-scatter characteristics of apoptotic thymocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa™ X-20 and FlowJo™ software. Data shown on this Technical Data Sheet are not lot specific.

Flow cytometric analysis of Recombinant Mouse TIM-3 protein binding blockade to phosphatidylserine expressed on apoptotic Mouse thymocytes by Purified NA/LE Rat Anti-Mouse CD366 (TIM-3) antibody. BALB/c Mouse thymocytes were cultured in the presence of 1 µM of Dexamethasone for 5 h (37°C) to induce apoptosis. Apoptotic thymocytes (1 x 10^6 cells/0.1 ml final volume) were mixed with Recombinant Mouse TIM-3 Fc Chimera Protein (5 µg test dose; R&D Systems, Cat. No. 1529-TM-050) preincubated (30 min 4°C) with either Purified NA/LE Rat Anti-Mouse CD366 (TIM-3) antibody (Cat. No. 569318; Solid Line) or Purified NA/LE Rat IgG2a Isotype Control (Cat. No. 554687; Dotted Line) at the indicated test doses. The cells were washed and secondarily stained with Biotin Goat Anti-Human IgG, Fc fragment specific (Biotin Anti-Human IgG Fc; Jackson ImmunoResearch, Cat. No. 109-065-190) followed by PE Streptavidin (Cat. No. 554061). The graphs showing the percentage of cells bound with Recombinant TIM-3+ (% Recombinant TIM-3+ Cells) after preincubation with TIM-3-specific Blocking Antibody (or Ig Isotype Control) were derived from gated events with the forward and side light-scatter characteristics of apoptotic thymocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa™ X-20 and FlowJo™ software. Data shown on this Technical Data Sheet are not lot specific.


BD Pharmingen™ Purified NA/LE Rat Anti-Mouse CD366 (TIM-3)

규제 상태 범례
Becton, Dickinson and Company의 명시적인 서면 승인 없이는 사용 하실 수 없습니다.
준비 및 보관
제품 고시
- Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.
- Since applications vary, each investigator should titrate the reagent to obtain optimal results.
- Please refer to http://regdocs.bd.com to access safety data sheets (SDS).
- An isotype control should be used at the same concentration as the antibody of interest.
관련 제품



The RMT3-23 monoclonal antibody specifically recognizes CD366 which is also known as TIM-3 (T-cell immunoglobulin and mucin domain-containing 3, T-cell immunoglobulin mucin receptor 3, or T-cell membrane protein 3). CD366 (TIM-3) is ~31 kDa type I transmembrane glycoprotein encoded by Havcr2 (Hepatitis A virus cellular receptor 2) that belongs to the TIM family within the immunoglobulin superfamily (IgSF). CD366 (TIM-3) is comprised of one Ig-like V-type domain followed by a serine/threonine-rich mucin stalk region in its extracellular region, a transmembrane segment, and a tyrosine phosphorylation motif in its cytoplasmic tail. CD366 (TIM-3) expression is upregulated on subpopulations of activated myeloid cells including macrophages, monocytes, dendritic cells (DC), microglia, mast cells as well as on Type-1 CD4+ (Th1-like) T cells, cytotoxic CD8+ T cells, regulatory T cells (Treg), and natural killer (NK) cells. CD366 (TIM-3) functions as an inhibitory receptor that helps maintain immunological homeostasis and self-tolerance. It may also serve an immune checkpoint molecule that inhibits antitumor immunity and promotes T cell exhaustion. Crosslinking of cell surface CD366 (TIM-3) by Galectin-9 binding downregulates Th1-like and CD8+ T cell responses and can promote Treg or myeloid-derived suppressor cells. CD366 (TIM-3) enables DC to bind phosphatidyl serine expressed by apoptotic cells, phagocytize these cells to suppress inflammation and promote antigen cross-presentation. CD366 (TIM-3) can also bind to high mobility group protein B1 (HMGB1) and inhibit stimulation of the immune response to nucleic acids released by dying tumor cells. RMT3-23 reportedly recognizes CD366 (TIM-3) derived from either BALB/c or C57BL/6 mice that have different Havcr2 polymorphisms.
개발 참고 자료 (11)
-
Anderson AC, Joller N, Kuchroo VK. Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation.. Immunity. 2016; 44(5):989-1004. (Biology). 참조 보기
-
Anderson AC, Xiao S, Kuchroo VK. Tim protein structures reveal a unique face for ligand binding.. Immunity. 2007; 26(3):273-5. (Biology). 참조 보기
-
Chiba S, Baghdadi M, Akiba H, et al. Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1.. Nat Immunol. 2012; 13(9):832-42. (Biology). 참조 보기
-
Nakae S, Iikura M, Suto H, et al. TIM-1 and TIM-3 enhancement of Th2 cytokine production by mast cells.. Blood. 2007; 110(7):2565-8. (Clone-specific: Flow cytometry). 참조 보기
-
Nakayama M, Akiba H, Takeda K, et al. Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation. Blood. 2009; 113(16):3821-3830. (Clone-specific). 참조 보기
-
Ngiow SF, von Scheidt B, Akiba H, Yagita H, Teng MW, Smyth MJ. Anti-TIM3 antibody promotes T cell IFN-γ-mediated antitumor immunity and suppresses established tumors.. Cancer Res. 2011; 71(10):3540-51. (Clone-specific: Flow cytometry). 참조 보기
-
Oikawa T1, Kamimura Y, Akiba H, et al. Preferential involvement of Tim-3 in the regulation of hepatic CD8+ T cells in murine acute graft-versus-host disease.. J Immunol. 2006; 177(7):4281-4287. (Immunogen: Flow cytometry, Immunohistochemistry, In vivo exacerbation). 참조 보기
-
Sabatos-Peyton CA, Nevin J, Brock A, et al. Blockade of Tim-3 binding to phosphatidylserine and CEACAM1 is a shared feature of anti-Tim-3 antibodies that have functional efficacy.. Oncoimmunology. 7(2):e1385690. (Clone-specific: Blocking, Flow cytometry). 참조 보기
-
Sakuishi K, Ngiow SF, Sullivan JM, et al. TIM3+FOXP3+ regulatory T cells are tissue-specific promoters of T-cell dysfunction in cancer.. Oncoimmunology. 2013; 2(4):e23849. (Clone-specific: Flow cytometry). 참조 보기
-
Veenstra RG, Taylor PA, Zhou Q, et al. Contrasting acute graft-versus-host disease effects of Tim-3/galectin-9 pathway blockade dependent upon the presence of donor regulatory T cells.. Blood. 2012; 120(3):682-90. (Biology). 참조 보기
-
Zhu C, Anderson AC, Schubart A, et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity.. Nat Immunol. 2005; 6(12):1245-52. (Methodology). 참조 보기
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.